Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 2.57
2.39 %
$ 275 M
Market Cap
-4.94
P/E
ACRS - GROSS PROFIT
Gross Profit ACRS - Aclaris Therapeutics, Inc.
13.2 M
LAST VALUE
153.57%
2 YEAR CAGR
32.36%
5 YEAR CAGR
0.00%
10 YEAR CAGR